Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 211 AL 225

Reliability of peak treadmill exercise tests in mild Alzheimer disease

Anderson HS, Kluding PM, Gajewski BJ, Donnelly JE, Burns JM.

Int J Neurosci. 2011 Aug;121(8):450-6. doi: 10.3109/00207454.2011.574762. Epub 2011 May 17.

Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library

Larbanoix L, Burtea C, Ansciaux E, Laurent S, Mahieu I, Vander Elst L, Muller RN.

Peptides. 2011 Jun;32(6):1232-43. doi: 10.1016/j.peptides.2011.04.026. Epub 2011 May 6.

Proteasome degradation of brain cytosolic tau in Alzheimer's disease

Yen SS.

Int J Clin Exp Pathol. 2011 Apr;4(4):385-402. Epub 2011 Apr 28.

BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity

Evin G, Lessene G, Wilkins S.

Recent Pat CNS Drug Discov. 2011 May 1;6(2):91-106. doi: 10.2174/157488911795933938.

Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies

Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck CH, Gold M.

Curr Alzheimer Res. 2011 Aug;8(5):592-606. doi: 10.2174/156720511796391935.

Transgenic mice as a model for Alzheimer's disease

Lithner CU, Hedberg MM, Nordberg A.

Curr Alzheimer Res. 2011 Dec;8(8):818-31. doi: 10.2174/156720511798192736.

Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab

Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, D'Onofrio G, Logroscino G, Pilotto A, Solfrizzi V.

Curr Alzheimer Res. 2011 Dec;8(8):808-17. doi: 10.2174/156720511798192718.

Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein

Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, Walsh DM, Rowan MJ.

J Neurosci. 2011 May 18;31(20):7259-63. doi: 10.1523/JNEUROSCI.6500-10.2011.

Selenium and Alzheimer's disease: a systematic review

Loef M, Schrauzer GN, Walach H.

J Alzheimers Dis. 2011;26(1):81-104. doi: 10.3233/JAD-2011-110414.

Geriatric epilepsy: research and clinical directions for the future

Roberson ED, Hope OA, Martin RC, Schmidt D.

Epilepsy Behav. 2011 Sep;22(1):103-11. doi: 10.1016/j.yebeh.2011.04.005. Epub 2011 May 19.

Impairment of the activity of the plasma membrane Ca²⁺-ATPase in Alzheimer's disease

Mata AM, Berrocal M, Sepúlveda MR.

Biochem Soc Trans. 2011 Jun;39(3):819-22. doi: 10.1042/BST0390819.

[The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice]

Li MH, Wang PJ, Chen SQ, Zhang W, Gao XL.

Zhonghua Yi Xue Za Zhi. 2011 Apr 5;91(13):876-9.

Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion

Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM.

Prog Neurobiol. 2011 Aug;94(3):296-306. doi: 10.1016/j.pneurobio.2011.05.001. Epub 2011 May 11.

Amyloid-β: the seeds of darkness

Fodero-Tavoletti MT, Villemagne VL, Rowe CC, Masters CL, Barnham KJ, Cappai R.

Int J Biochem Cell Biol. 2011 Sep;43(9):1247-51. doi: 10.1016/j.biocel.2011.05.001. Epub 2011 May 11.

A clinical perspective: anti tau's treatment in Alzheimer's disease

Fuentes P, Catalan J.

Curr Alzheimer Res. 2011 Sep;8(6):686-8. doi: 10.2174/156720511796717221.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias